<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24692" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Mallory Bodies</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kurtovic</surname>
            <given-names>Emir</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Limaiem</surname>
            <given-names>Faten</given-names>
          </name>
          <aff>University of Tunis El Manar, Tunis Faculty of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Emir Kurtovic declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Faten Limaiem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>30</day>
          <month>4</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24692.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Mallory bodies (MBs), also known as Mallory-Denk bodies (MDBs), are cytoplasmic hyaline inclusions of hepatocytes, once thought to be specific for alcohol-related steatohepatitis (ASH).&#x000a0;MDBs&#x000a0;are&#x000a0;also seen in other liver diseases,&#x000a0;including metabolic dysfunction-associated steatohepatitis (MASH)&#x02014;formerly known as nonalcoholic steatohepatitis (NASH),<xref ref-type="bibr" rid="article-24692.r1">[1]</xref> cholestatic liver diseases, primary biliary cirrhosis (PBC), and hepatocellular carcinoma (HCC).<xref ref-type="bibr" rid="article-24692.r2">[2]</xref> In 1911, Frank Burr Mallory discovered these&#x000a0;histological findings&#x000a0;while examining the hepatocytes of patients with alcoholic hepatitis. In 1975, Helmut Denk found the first animal model of MDBs by feeding mice griseofulvin, resulting in the renaming&#x000a0;of these formations.<xref ref-type="bibr" rid="article-24692.r3">[3]</xref>&#x000a0;See <bold>Image.</bold> Mallory&#x000a0;Bodies. As a result of transitioning from&#x000a0;mouse models to applicability in humans, MDBs&#x000a0;were found to primarily comprise&#x000a0;keratins, chaperones, co-transporters, and other proteins. Broadly, they&#x000a0;are categorized as classic, non-keratinous, rounded, and variants for clinicians grading patient biopsies. Histologically, these subtypes are&#x000a0;specified when staging the disease process.</p>
        <p>MDBs are formed by stress mechanisms leading to cell cycle dysregulation, which impairs the generation of normal hepatocytes and&#x000a0;non-hepatic&#x000a0;cells in the body. Since cell cycle dysregulation is a hallmark of the gastrointestinal (GI) diseases mentioned above, MDBs are clinically correlated. To an extent, the formation of MDBs is protective in inflamed tissue to limit further inflammation, leading to fibrosis, but several stressors may eventually accelerate the pathology. The learning activity below discusses the molecular basis of MDBs, the mechanisms by which they are formed, and evidence-based literature on clinical correlations. Typically, the interprofessional team may consist of primary care, gastroenterology, and pathology, leading to continued staging of disease progression. Students within these fields are equipped&#x000a0;to identify the histological features of MDBs as they progress in training.</p>
      </sec>
      <sec id="article-24692.s2" sec-type="Causes">
        <title>Causes</title>
        <p>
<bold>Hepatocytes</bold>
</p>
        <p>In general,&#x000a0;MDB formation&#x000a0;is known to present&#x000a0;in liver diseases. Pertinent liver diseases include hepatitis B and C, alcoholic liver disease, metabolic function-associated steatotic liver disease (MASLD)&#x02014;formerly known as nonalcoholic fatty liver disease (NAFLD),<xref ref-type="bibr" rid="article-24692.r1">[1]</xref> hepatocellular carcinoma (HCC), focal nodular hyperplasia, Wilson disease, and copper toxicosis.<xref ref-type="bibr" rid="article-24692.r4">[4]</xref>&#x000a0;Pertinent gallbladder diseases include primary biliary cholangitis (PBC), chronic cholestasis, and cholangiocarcinoma. However,&#x000a0;MDBs may also present&#x000a0;following glucocorticoid therapy, intestinal bypass surgery for obesity, Weber-Christian disease, von Gierke disease, radiation pneumonitis, asbestosis, amiodarone, beta lipoproteinemia, porphyria cutanea tarda, antitrypsin deficiency, Indian childhood cirrhosis, perhexiline maleate hepatitis, cirrhosis, 2&#x02032;3&#x02032;-dideoxyinosine diethylaminoetheoxyhex-estriol&#x02013;induced hepatitis, hepatic adenoma, sclerosing hyaline necrosis in Bloom syndrome, and congenital fibrosis.<xref ref-type="bibr" rid="article-24692.r5">[5]</xref></p>
        <p>
<bold>Non-Hepatic Cells</bold>
</p>
        <p>MDBs are rarely&#x000a0;present in non-hepatic cells, but examples exist in asbestosis, renal cell carcinoma, and type 2 pneumocytes.<xref ref-type="bibr" rid="article-24692.r3">[3]</xref>&#x000a0;Clinical correlations discuss recent findings in lesser-known diseases detailed below.</p>
      </sec>
      <sec id="article-24692.s3" sec-type="Anatomical Pathology">
        <title>Anatomical Pathology</title>
        <p>P62 (a sequestosome), ubiquitin, and intermediate filament proteins keratins 8 and 18 (K8/18) are the significant elements that make up a Mallory body.&#x000a0;In normal conditions, K8 and 18 are present in 1 to 1 ratio.<xref ref-type="bibr" rid="article-24692.r6">[6]</xref> Protein misfolding, proteasome overload, a ratio of K8 greater than K18, and transamidation of K8 contribute to MDB formation.<xref ref-type="bibr" rid="article-24692.r7">[7]</xref>&#x000a0;K8 is insoluble and not easily amenable to degradation, resulting in MDBs. Overexpression of K18 inhibits MDB formation.<xref ref-type="bibr" rid="article-24692.r3">[3]</xref>&#x000a0;K8 is likelier to change&#x000a0;the helical shape to cross-&#x003b2; sheets, resulting in&#x000a0;MDB formation.&#x000a0;Formations without&#x000a0;K8 do not make MDB, thus linking cross-&#x003b2; sheets as necessary for MDB development.<xref ref-type="bibr" rid="article-24692.r8">[8]</xref><xref ref-type="bibr" rid="article-24692.r9">[9]</xref><xref ref-type="bibr" rid="article-24692.r10">[10]</xref>&#x000a0;A similar&#x000a0;cross-linking is also seen in protein aggregation disorders such as prion disease and Alzheimer disease.</p>
        <p>The results of recent studies continue to extrapolate the correlation of MDBs to other cell cycle markers, including stress-activated markers such as p16 and p21, suggesting a role in cellular senescence rather than just liver pathology.<xref ref-type="bibr" rid="article-24692.r11">[11]</xref>&#x000a0;Macrophages involved in the inflammatory process are transcriptionally heterogeneous.<xref ref-type="bibr" rid="article-24692.r12">[12]</xref>&#x000a0;Accordingly, aggregates such as MDBs are also implicated in&#x000a0;activating nuclear factor-&#x003ba;B, though the downstream effects on inflammation are unknown.<xref ref-type="bibr" rid="article-24692.r13">[13]</xref>&#x000a0;The exact mechanism by which inflammation is upregulated is also unknown, though&#x000a0;occurring at several stages of the cell regeneration process.</p>
      </sec>
      <sec id="article-24692.s4" sec-type="Clinical Pathology">
        <title>Clinical Pathology</title>
        <p>Mallory-Denk bodies are ubiquitously found in alcohol-realted steatohepatitis (ASH), MASH, PBC, and HCC, among other&#x000a0;GI disorders. Hepatotoxicity due to medications also causes MDBs; most recently, the use of amiodarone was directly linked.<xref ref-type="bibr" rid="article-24692.r14">[14]</xref>&#x000a0;The presence or absence of MDBs can determine a final diagnosis if the consultation of a pathologist is involved. Recently, MDBs were found in patients with COVID-19, suggesting a correlation to the pathological transformation of pneumocytes.<xref ref-type="bibr" rid="article-24692.r15">[15]</xref>&#x000a0;Formations appearing similar to MDBs were also seen in ovarian fibromas that underwent torsion.<xref ref-type="bibr" rid="article-24692.r16">[16]</xref>&#x000a0;The clinical correlations to conditions outside of gastroenterology are not yet diagnostic.&#x000a0;Though MDBs indicate pathology, they do not typically inform the prognosis or influence the mortality rate.&#x000a0;</p>
        <p>Cytoplasmic inclusion bodies, intracytoplasmic hyaline bodies (IHB), and&#x000a0;MDBs can be&#x000a0;visualized in HCC.<xref ref-type="bibr" rid="article-24692.r17">[17]</xref> MDB was linked to the steatohepatitis variant of HCC,&#x000a0;whereas intracytoplasmic hyaline bodies (IHBs) were not. However, the presence of IHBs correlates with shorter survival than MDBs.<xref ref-type="bibr" rid="article-24692.r18">[18]</xref> MDBs&#x000a0;are distinguishable from other cytoplasmic inclusions, such as IHBs. For example, MDBs consist of ubiquitin, p62, and keratin,&#x000a0;whereas IHBs only consist of ubiquitin and p62. IHBs have intracytoplasmic hyaline bodies and are a morphological precursor to MDBs.<xref ref-type="bibr" rid="article-24692.r3">[3]</xref><xref ref-type="bibr" rid="article-24692.r19">[19]</xref></p>
      </sec>
      <sec id="article-24692.s5" sec-type="Morphology">
        <title>Morphology</title>
        <p>Mallory-Denk bodies&#x000a0;are predominantly filamentous cytoplasmic inclusions, ranging from 3 to 24 nm&#x000a0;versus 10 nm of intermediate filaments.&#x000a0;</p>
        <p>The&#x000a0;bodies&#x000a0;are classified as:</p>
        <list list-type="bullet">
          <list-item>
            <p>Type I: Parallels filaments</p>
          </list-item>
          <list-item>
            <p>Type II: Randomly oriented filaments occurring in the periphery</p>
          </list-item>
          <list-item>
            <p>Type III: Granular, amorphous, and occur around the center</p>
          </list-item>
        </list>
        <p>MDBs occur in ballooned hepatocytes, but not all ballooned hepatocytes lead to MDBs; both features indicate active tissue inflammation. The formation occurs in stages:</p>
        <list list-type="order">
          <list-item>
            <p>Misfolded proteins (typically degraded by the proteasome pathway)</p>
          </list-item>
          <list-item>
            <p>Young MDB in ballooned hepatocytes</p>
          </list-item>
          <list-item>
            <p>Mature MDB</p>
          </list-item>
        </list>
        <p>They are visible via hematoxylin-eosin stain; however, immunohistochemical staining of cytokeratin or ubiquitin is more sensitive and diagnostic. Pericellular fibrosis and neutrophils tend to surround the hepatocytes with MDB,&#x000a0;causing satellitosis.<xref ref-type="bibr" rid="article-24692.r20">[20]</xref>&#x000a0;The distribution of MDB in the cells suggests different stages of their formation. For example, small cytoplasmic globular structures are early, large para-nuclear inclusions are mature, and those located in the periphery are considered old.<xref ref-type="bibr" rid="article-24692.r3">[3]</xref> MDB&#x000a0;are found in different liver zones and vary in location depending on the disease process. In&#x000a0;PBC and Wilson disease,&#x000a0;MDBs&#x000a0;are seen in zone 1, whereas in ASH and MASLD,&#x000a0;they&#x000a0;are present in zone 3.<xref ref-type="bibr" rid="article-24692.r4">[4]</xref></p>
      </sec>
      <sec id="article-24692.s6" sec-type="Mechanisms">
        <title>Mechanisms</title>
        <p>Before MDBs are formed, hepatocytes balloon, a response to oxidative stress, such as abnormal proteins (heat shock proteins) or fat, resulting in water accumulation in the hepatic cytoplasm.<xref ref-type="bibr" rid="article-24692.r4">[4]</xref>&#x000a0;Heat shock protein&#x000a0;formation&#x000a0;indicates cellular dysfunction.</p>
        <p>Three mechanisms describe the formation:</p>
        <list list-type="order">
          <list-item>
            <p>The first mechanism is that epigenetics (acetylation, methylation, and ubiquitination of histones) contribute to&#x000a0;genetic regulation during MDB formation. Hepatocytes have shown stored memory of previous inciting toxicity, leading to gene silencing.</p>
          </list-item>
          <list-item>
            <p>The second pathway is the shift from the 26S proteasome to the immunoproteasome, though the exact mechanism of gene regulation is unknown. The 26S proteasome degrades intracellular (cytosolic, nuclear, and membrane) proteins.
<list list-type="bullet"><list-item><p>The 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) agent induces MDB&#x000a0;by changing 26s proteasome to immunoproteasome, accumulating protein.&#x000a0;</p></list-item><list-item><p>When chaperones (ie, heat shock protein 70) and proteins that refold misfolded proteins are uncontrolled, inclusion bodies such as MDB may form.</p></list-item><list-item><p>Toxins such as alcohol&#x000a0;or DDC cause chaperones to become defective.</p></list-item><list-item><p>Misfolded proteins are targeted by ubiquitination, which signals the molecule via p62 for proteasomal and autophagic degradation.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>The third is the chronic activation of the toll-like signaling&#x000a0;receptors (TLR)&#x000a0;that&#x000a0;stimulate proinflammatory and cell growth pathways.
<list list-type="bullet"><list-item><p>Interferon (IFR)-&#x003b3; and tumor necrosis factor (TNF)-&#x003b1; stimulate TLR, which causes up-regulation of growth factors, resulting in the proliferation of MDB-forming cells.</p></list-item><list-item><p>Drugs can also create a shift to the formation of the immunoproteasome rather than the 26s proteasome.</p></list-item><list-item><p>DDC also stimulates TNF-&#x003b1; and IFN-&#x003b3; expression, activating the TLR.&#x000a0;Proinflammatory cytokines TNF-&#x003b1; and IFN-&#x003b3; via TLR signaling cause up-regulation of the immunoproteasome and down-regulation of the 26s proteasome, resulting in undigested proteins and MDB formation<italic toggle="yes">.</italic><xref ref-type="bibr" rid="article-24692.r3">[3]</xref><xref ref-type="bibr" rid="article-24692.r7">[7]</xref><xref ref-type="bibr" rid="article-24692.r21">[21]</xref><xref ref-type="bibr" rid="article-24692.r22">[22]</xref><xref ref-type="bibr" rid="article-24692.r23">[23]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p>All&#x000a0;3 mechanisms describe different stress-induced points in the cell cycle, either at deoxyribonucleic acid replication, transcription, or translation. Depending on the inciting event, these mechanisms can occur simultaneously, sequentially, or separately.</p>
      </sec>
      <sec id="article-24692.s7" sec-type="Clinicopathologic Correlations">
        <title>Clinicopathologic Correlations</title>
        <p>
<bold>Liver Diseases</bold>
</p>
        <p>Mallory-Denk bodies&#x000a0;as a marker for MASLD depend on the histological scoring system. Matteoni et al emphasized the formation of MDBs, while Kleiner et al, which is a more accepted scoring system, did not.<xref ref-type="bibr" rid="article-24692.r3">[3]</xref>&#x000a0;Kleiner's system emphasizes fibrosis, steatosis, inflammatory inflammation, and ballooning hepatocytes.&#x000a0;Some recommend&#x000a0;that the KRT8/K18 ratio&#x000a0;is a biomarker for HCC.<xref ref-type="bibr" rid="article-24692.r6">[6]</xref>&#x000a0;In patients who use alcohol, a sensitive and specific test to detect MDB is Ub/immunostaining.&#x000a0;Inclusions occur in the liver, muscle, and neural tissues, suggesting a common intracellular network of protein synthesis and degradation and responsiveness to stressors. MDBs can be considered a protective mechanism against cell injury or, rather, a step in the pathogenesis of liver damage.<xref ref-type="bibr" rid="article-24692.r4">[4]</xref>&#x000a0;The MDBs seem to reoccur within 2 to 3 days in animal models when alcohol use ceases after previous use of alcohol.<xref ref-type="bibr" rid="article-24692.r20">[20]</xref></p>
        <p>
<bold>Metabolic Dysfunction-Associated Steatohepatitis</bold>
</p>
        <p>Clinical findings of MASH (jaundice, leukocytosis, fever) may demonstrate classical histological findings of steatosis; however, few or no MDBs could be seen. MDBs are less developed in MASH, which tends to be less severe as a hepatic pathology. MASH in children often does not&#x000a0;exhibit the formation of&#x000a0;MDBs, suggesting that aging may play a role.&#x000a0;</p>
      </sec>
      <sec id="article-24692.s8" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Areas for Further Research</bold>
</p>
        <p>Abnormal protein folding is known to cause other diseases, including Alzheimer disease. A recent literature review demonstrated common ground between the mechanisms&#x000a0;involved in Alzheimer disease and MDB formation. Due to&#x000a0;the similarities, future studies should test betaine or S-adenosyl-L-methionine's (SAMe) effect on Alzheimer disease, as they have&#x000a0;been shown to prevent MDB formation.<xref ref-type="bibr" rid="article-24692.r5">[5]</xref> Beta sheets that are present in amyloid deposits are also present in MDB.<xref ref-type="bibr" rid="article-24692.r3">[3]</xref></p>
        <p>In patients with alcoholic liver disease, about 70% to 75% have MDB. However, in patients with MASLD, MDB ranges from 7% to 90%.<xref ref-type="bibr" rid="article-24692.r4">[4]</xref> The wide range of MDBs in MASLD is likely the result of not having the specific amount, which qualifies as excessive alcohol use,&#x000a0;categorizing the patient as alcoholic rather than non-alcoholic. In severe alcoholic hepatitis, non-responders to corticosteroids had high histopathological findings of ballooning degeneration and MDB, suggesting that&#x000a0;histopathological&#x000a0;findings can identify those who may respond to corticosteroids.<xref ref-type="bibr" rid="article-24692.r24">[24]</xref> Study results have shown that autophagy contributes to MDB degradation along with other intracellular compartments.<xref ref-type="bibr" rid="article-24692.r25">[25]</xref><xref ref-type="bibr" rid="article-24692.r26">[26]</xref> Fenofibrate, a fibric acid derivative that lowers cholesterol, prevents MDB formation by preventing disruption of the intermediate filament.<xref ref-type="bibr" rid="article-24692.r27">[27]</xref></p>
        <p>Methyl donors like betaine and SAMe prevent MDB formation. SAMe prevents the demethylation of histones, which occurs with DDC. In contrast, betaine prevents MDB formation by preventing the changes in methionine metabolism, and betaine-homocysteine methyltransferase (BHMT) methionine increases from homocysteine.<xref ref-type="bibr" rid="article-24692.r7">[7]</xref><xref ref-type="bibr" rid="article-24692.r21">[21]</xref><xref ref-type="bibr" rid="article-24692.r28">[28]</xref>&#x000a0;TLR and p62 pathways are also prevented by betaine and SAMe.</p>
        <p>These identified markers for MDBs are potential areas for novel therapeutic intervention at the primary, secondary, tertiary, and quaternary protein formation levels and in patients undergoing treatment for related conditions.<xref ref-type="bibr" rid="article-24692.r29">[29]</xref><xref ref-type="bibr" rid="article-24692.r30">[30]</xref>&#x000a0;Though the results in animal studies do not fully apply to clinical medicine, specifically when the MDBs revert or recur, the implications may benefit clinicians treating patients with GI conditions.</p>
        <p>
<bold>Interprofessional Collaboration</bold>
</p>
        <p>Given the established process for identifying, differentiating, and diagnosing conditions based on the presence or absence of MDBs, further inclusion or exclusion criteria could refine the diagnostic process. Though the molecular basis is elucidated, several downstream effects of epigenetics, proteasome regulation, TLR signaling, and immunomodulation are unknown, though the aggregations resemble several protein-aggregating diseases. The role of MDBs in lesser-known reproductive or pulmonary diseases could be explored.</p>
      </sec>
      <sec id="article-24692.s9">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24692&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24692">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24692/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24692">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-24692.s10">
        <fig id="article-24692.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Mallory Bodies.&#x000a0;Mallory bodies, also known as Mallory-Denk bodies, are cytoplasmic hyaline inclusions of hepatocytes, once thought to be specific for alcoholic hepatitis. Contributed by&#x000a0;O Chaigasame, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mallory__bodies" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-24692.s11">
        <title>References</title>
        <ref id="article-24692.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rinella</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Examining the Nomenclature Change From NAFLD and NASH to MASLD and MASH.</article-title>
            <source>Gastroenterol Hepatol (N Y)</source>
            <year>2023</year>
            <month>Nov</month>
            <volume>19</volume>
            <issue>11</issue>
            <fpage>697</fpage>
            <page-range>697-699</page-range>
            <pub-id pub-id-type="pmid">38405223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aishima</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fujita</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mano</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Iguchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Taketomi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maehara</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Oda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tsuneyoshi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>p62+ Hyaline inclusions in intrahepatic cholangiocarcinoma associated with viral hepatitis or alcoholic liver disease.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>134</volume>
            <issue>3</issue>
            <fpage>457</fpage>
            <page-range>457-65</page-range>
            <pub-id pub-id-type="pmid">20716803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zatloukal</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Stumptner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Strnad</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Harada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Toivola</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Cadrin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Omary</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>From Mallory to Mallory-Denk bodies: what, how and why?</article-title>
            <source>Exp Cell Res</source>
            <year>2007</year>
            <month>Jun</month>
            <day>10</day>
            <volume>313</volume>
            <issue>10</issue>
            <fpage>2033</fpage>
            <page-range>2033-49</page-range>
            <pub-id pub-id-type="pmid">17531973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Basaranoglu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Turhan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sonsuz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Basaranoglu</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Mallory-Denk Bodies in chronic hepatitis.</article-title>
            <source>World J Gastroenterol</source>
            <year>2011</year>
            <month>May</month>
            <day>07</day>
            <volume>17</volume>
            <issue>17</issue>
            <fpage>2172</fpage>
            <page-range>2172-7</page-range>
            <pub-id pub-id-type="pmid">21633525</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>French</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Mendoza</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>The mechanisms of Mallory-Denk body formation are similar to the formation of aggresomes in Alzheimer's disease and other neurodegenerative disorders.</article-title>
            <source>Exp Mol Pathol</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>100</volume>
            <issue>3</issue>
            <fpage>426</fpage>
            <page-range>426-33</page-range>
            <pub-id pub-id-type="pmid">27068270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Golob-Schwarzl</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bettermann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Kessler</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Unterluggauer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Krassnig</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kojima</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Hoshida</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Bardeesy</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Svendova</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Schimek</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Diwoky</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lipfert</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mahajan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Stumptner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Th&#x000fc;ringer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fr&#x000f6;hlich</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Stojakovic</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>KPR</given-names>
              </name>
              <name>
                <surname>Kolbe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>R&#x000fc;licke</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Magin</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Strnad</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kiemer</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Moriggl</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Haybaeck</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype.</article-title>
            <source>Transl Oncol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>256</fpage>
            <page-range>256-268</page-range>
            <pub-id pub-id-type="pmid">30439626</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>French</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Bardag-Gorce</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Oliva</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Mallory-Denk body pathogenesis revisited.</article-title>
            <source>World J Hepatol</source>
            <year>2010</year>
            <month>Aug</month>
            <day>27</day>
            <volume>2</volume>
            <issue>8</issue>
            <fpage>295</fpage>
            <page-range>295-301</page-range>
            <pub-id pub-id-type="pmid">21161012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahajan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Klingstedt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Thueringer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kashofer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Haybaeck</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Denk</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Abuja</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Zatloukal</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Cross &#x003b2;-sheet conformation of keratin 8 is a specific feature of Mallory-Denk bodies compared with other hepatocyte inclusions.</article-title>
            <source>Gastroenterology</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>141</volume>
            <issue>3</issue>
            <fpage>1080</fpage>
            <page-range>1080-1090.e1-7</page-range>
            <pub-id pub-id-type="pmid">21699779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murray</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Sawaya</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Salwinski</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Seidler</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Eisenberg</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Identifying amyloid-related diseases by mapping mutations in low-complexity protein domains to pathologies.</article-title>
            <source>Nat Struct Mol Biol</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>29</volume>
            <issue>6</issue>
            <fpage>529</fpage>
            <page-range>529-536</page-range>
            <pub-id pub-id-type="pmid">35637421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Somlapura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gottschalk</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lahiri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kufferath</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pabst</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>R&#x000fc;licke</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Graier</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Denk</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zatloukal</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Different Roles of p62 (SQSTM1) Isoforms in Keratin-Related Protein Aggregation.</article-title>
            <source>Int J Mol Sci</source>
            <year>2021</year>
            <month>Jun</month>
            <day>09</day>
            <volume>22</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">34207662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Denk</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Abuja</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Zatloukal</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Mallory-Denk bodies and hepatocellular senescence: a causal relationship?</article-title>
            <source>Virchows Arch</source>
            <year>2024</year>
            <month>Apr</month>
            <volume>484</volume>
            <issue>4</issue>
            <fpage>637</fpage>
            <page-range>637-644</page-range>
            <pub-id pub-id-type="pmid">38289501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zhong</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Jia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Single-cell transcriptomes identifies characteristic features of mouse macrophages in liver Mallory-Denk bodies formation.</article-title>
            <source>Exp Mol Pathol</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>127</volume>
            <fpage>104811</fpage>
            <pub-id pub-id-type="pmid">35850229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Trnka</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Guan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Greer</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Burlingame</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Correia</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>A Novel Mechanism for NF-&#x003ba;B-activation via I&#x003ba;B-aggregation: Implications for Hepatic Mallory-Denk-Body Induced Inflammation.</article-title>
            <source>Mol Cell Proteomics</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>12</issue>
            <fpage>1968</fpage>
            <page-range>1968-1986</page-range>
            <pub-id pub-id-type="pmid">32912968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pop</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Halegoua-DeMarzio</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Barnhart</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kleiner</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Avigan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chalasani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fontana</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Barritt</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Durazo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hayashi</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Navarro</surname>
                <given-names>VJ</given-names>
              </name>
            </person-group>
            <article-title>Amiodarone and Dronedarone Causes Liver Injury with Distinctly Different Clinical Presentations.</article-title>
            <source>Dig Dis Sci</source>
            <year>2024</year>
            <month>Apr</month>
            <volume>69</volume>
            <issue>4</issue>
            <fpage>1479</fpage>
            <page-range>1479-1487</page-range>
            <pub-id pub-id-type="pmid">38416280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zubieta-Calleja</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Zubieta-DeUrioste</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>de Jes&#x000fa;s Montelongo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sanchez</surname>
                <given-names>MGR</given-names>
              </name>
              <name>
                <surname>Campoverdi</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Rocco</surname>
                <given-names>PRM</given-names>
              </name>
              <name>
                <surname>Battaglini</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ball</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pelosi</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Morphological and functional findings in COVID-19 lung disease as compared to Pneumonia, ARDS, and High-Altitude Pulmonary Edema.</article-title>
            <source>Respir Physiol Neurobiol</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>309</volume>
            <fpage>104000</fpage>
            <pub-id pub-id-type="pmid">36460252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krishnamurthy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Stillman</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Hecht</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Vyas</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Defining the Nature and Clinicopathologic Significance of Mallory-Denk-like Inclusions in Ovarian Fibromas: A Potential Degenerative Phenomenon Associated With Torsion.</article-title>
            <source>Int J Gynecol Pathol</source>
            <year>2024</year>
            <month>May</month>
            <day>01</day>
            <volume>43</volume>
            <issue>3</issue>
            <fpage>290</fpage>
            <page-range>290-295</page-range>
            <pub-id pub-id-type="pmid">37562060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kawasaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shioya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Takata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsubata</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Okanemasa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Takenaka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Terauchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamashita</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kumagai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A case of bone metastasis of hepatocellular carcinoma: Mallory hyaline bodies can lead to the correct cytological diagnosis.</article-title>
            <source>Diagn Cytopathol</source>
            <year>2023</year>
            <month>Feb</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>E70</fpage>
            <page-range>E70-E74</page-range>
            <pub-id pub-id-type="pmid">36345980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aigelsreiter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Neumann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pichler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Halasz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zatloukal</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Berghold</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Douschan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rainer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Stauber</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Haybaeck</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Denk</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lackner</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis.</article-title>
            <source>Liver Int</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>600</fpage>
            <page-range>600-610</page-range>
            <pub-id pub-id-type="pmid">27885796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Byrnes</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Baral</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mercer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Joshi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wahby</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rorison</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>XM</given-names>
              </name>
              <name>
                <surname>Khambu</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Impaired hepatic autophagy exacerbates hepatotoxin induced liver injury.</article-title>
            <source>Cell Death Discov</source>
            <year>2023</year>
            <month>Feb</month>
            <day>21</day>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <pub-id pub-id-type="pmid">36810855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Denk</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stumptner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zatloukal</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Mallory bodies revisited.</article-title>
            <source>J Hepatol</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>689</fpage>
            <page-range>689-702</page-range>
            <pub-id pub-id-type="pmid">10782920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bardag-Gorce</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Oliva</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Villegas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fraley</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Amidi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dedes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Epigenetic mechanisms regulate Mallory Denk body formation in the livers of drug-primed mice.</article-title>
            <source>Exp Mol Pathol</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>84</volume>
            <issue>2</issue>
            <fpage>113</fpage>
            <page-range>113-21</page-range>
            <pub-id pub-id-type="pmid">18281034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Livneh</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cohen-Kaplan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cohen-Rosenzweig</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Avni</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ciechanover</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death.</article-title>
            <source>Cell Res</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>26</volume>
            <issue>8</issue>
            <fpage>869</fpage>
            <page-range>869-85</page-range>
            <pub-id pub-id-type="pmid">27444871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qian</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ding</surname>
                <given-names>WX</given-names>
              </name>
            </person-group>
            <article-title>SQSTM1/p62 and Hepatic Mallory-Denk Body Formation in Alcohol-Associated Liver Disease.</article-title>
            <source>Am J Pathol</source>
            <year>2023</year>
            <month>Oct</month>
            <volume>193</volume>
            <issue>10</issue>
            <fpage>1415</fpage>
            <page-range>1415-1426</page-range>
            <pub-id pub-id-type="pmid">36906265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shasthry</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Rastogi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bihari</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vijayaraghavan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Arora</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Sarin</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Histological activity score on baseline liver biopsy can predict non-response to steroids in patients with severe alcoholic hepatitis.</article-title>
            <source>Virchows Arch</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>472</volume>
            <issue>4</issue>
            <fpage>667</fpage>
            <page-range>667-675</page-range>
            <pub-id pub-id-type="pmid">29516163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harada</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Autophagy is involved in the elimination of intracellular inclusions, Mallory-Denk bodies, in hepatocytes.</article-title>
            <source>Med Mol Morphol</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-8</page-range>
            <pub-id pub-id-type="pmid">20340001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ke</surname>
                <given-names>PY</given-names>
              </name>
            </person-group>
            <article-title>Diverse Functions of Autophagy in Liver Physiology and Liver Diseases.</article-title>
            <source>Int J Mol Sci</source>
            <year>2019</year>
            <month>Jan</month>
            <day>13</day>
            <volume>20</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">30642133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nikam</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Patankar</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Somlapura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lahiri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sachdev</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kratky</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Denk</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zatloukal</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Abuja</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>The PPAR&#x003b1; Agonist Fenofibrate Prevents Formation of Protein Aggregates (Mallory-Denk bodies) in a Murine Model of Steatohepatitis-like Hepatotoxicity.</article-title>
            <source>Sci Rep</source>
            <year>2018</year>
            <month>Aug</month>
            <day>28</day>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>12964</fpage>
            <pub-id pub-id-type="pmid">30154499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oliva</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bardag-Gorce</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Betaine prevents Mallory-Denk body formation in drug-primed mice by epigenetic mechanisms.</article-title>
            <source>Exp Mol Pathol</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>86</volume>
            <issue>2</issue>
            <fpage>77</fpage>
            <page-range>77-86</page-range>
            <pub-id pub-id-type="pmid">19073172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neuman</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Non-invasive Biomarkers of Liver Inflammation and Cell Death in Response to Alcohol Detoxification.</article-title>
            <source>Front Physiol</source>
            <year>2021</year>
            <volume>12</volume>
            <fpage>678118</fpage>
            <pub-id pub-id-type="pmid">34305638</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24692.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhong</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tao</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Altered regulation of LncRNA analysis of human alcoholic hepatitis with Mallory-Denk Bodies (MDBs) is revealed by RNA sequencing.</article-title>
            <source>Exp Mol Pathol</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>117</volume>
            <fpage>104559</fpage>
            <pub-id pub-id-type="pmid">33121977</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
